EGFR and cancer: HOTAIR, a LncRNA that serves as a therapeutic target in various types of cancer, has been silenced through an EGFR-targeting aptamer conjugated to a HOTAIR-specific siRNA, leading to a reduced viability, migration, and invasion of EGFR-positive TNBC cells (Wang et al., 2021).